​ Conditions: Persistent Isolated Chemotherapy-Induced Thrombocytopenia; Chemotherapy-Induced Thrombocytopenia; Gynecologic Cancers; Ovarian Cancer; Breast Cancer; Lung Cancer; Non-Small Cell Lung Cancer; Cervical Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer

Interventions: Drug: Romiplostim N01; Drug: All-trans retinoic acid

Sponsors: Peking University People’s Hospital; Peking University Cancer Hospital and Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking University International Hospital; Shanxi Province Cancer Hospital; Henan Provincial People’s Hospital; China-Japan Union Hospital, Sun Yat-sen University Cancer Center; Hebei Medical University Fourth Hospital; Tianjin Medical University Cancer Institute and Hospital

Recruiting Conditions: Persistent Isolated Chemotherapy-Induced Thrombocytopenia; Chemotherapy-Induced Thrombocytopenia; Gynecologic Cancers; Ovarian Cancer; Breast Cancer; Lung Cancer; Non-Small Cell Lung Cancer; Cervical Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
Interventions: Drug: Romiplostim N01; Drug: All-trans retinoic acid
Sponsors: Peking University People’s Hospital; Peking University Cancer Hospital and Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking University International Hospital; Shanxi Province Cancer Hospital; Henan Provincial People’s Hospital; China-Japan Union Hospital, Sun Yat-sen University Cancer Center; Hebei Medical University Fourth Hospital; Tianjin Medical University Cancer Institute and Hospital
Recruiting